The present study addressed the association of baseline pre-operative PLT count, MPV, coagulation profile including prothrombin time (PT), prothrombin ratio (PT ratio), activated partial thromboplastin time (aPTT), and aPPT ratio with demographic and tumoral parameters, and their impact on OS in patients with GBM. The gene discussed is F2; the disease is glioblastoma.